Summit Therapeutics Inc. and Lunit Inc. announced a research agreement to evaluate the use of Lunit SCOPE IO, Lunit?s AI-powered pathology platform, for tumor microenvironment analysis in support of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results